Atarax

This page contains recent news articles, when available, and an overview of Atarax but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.


Overview:

Atarax
(when available)

Pharmacology and use:
Hydroxyzine, a piperazine antihistamine structurally related to buclizine, cyclizine, and meclizine, is used to treat histamine-mediated pruritus or pruritus due to allergy, nausea and vomiting, and, in combination with an opiate agonist, anxiolytic pain. Hydroxyzine is also used as a perioperative sedative and anxiolytic and to manage acute alcohol withdrawal. Hydroxyzine's active metabolite, cetirizine, is also used as an H1-antagonist. For symptomatic relief of anxiety and tension associated with psychoneurosis and as an adjunct in organic disease states in which anxiety is manifested. Useful in the management of pruritus due to allergic conditions such as chronic urticaria.

Mechanism Of Action:
Hydroxyzine competes with histamine for binding at H1-receptor sites on the effector cell surface, resulting in suppression of histaminic edema, flare, and pruritus. The sedative properties of hydroxyzine occur at the subcortical level of the CNS. Secondary to its central anticholinergic actions, hydroxyzine may be effective as an antiemetic.

News Articles on Hydroxyzine

Treatment for Grover's Disease Geared Toward Relieving Itching and Rash  -  ‎Dec 31, 2009‎
...along with antihistamines, such as diphenhydramine (Benadryl) or hydroxyzine (Vistaril, Atarax). If those medications don't provide enough relief, ... Hartford Courant

Popular resolutions fall into three main categories  -  ‎Dec 27, 2009‎
Approved by the US Food and Drug Administration, this method uses a combination of two medicines, scopolamine and Atarax, to help block nicotine receptors ... News Chief

Industry Issues in Raising Capital: Pharmaceuticals  -  ‎Dec 14, 2009‎
Inc.'s (NYSE: MRK) Aramine, Pfizer's Atarax and GlaxoSmithKline plc's (NYSE: GSK) Compazine. A second investment concern lies in the massive number of ... NASDAQ

Brand Names/Synonyms:
Atarax is also known by the following brand names and/or synonymsAlamon; Atara; Atarax; Atarax Base; Ataraxoid; Atarazoid; Atarox; Atazina; Aterax; CHEMBANK2612; Deinait; Durrax; Equipoise; Equipose; Fenarol; HSDB 3098; Hidroxizina [Inn-Spanish]; Hy-Pam 25; Hychotine; Hydroksyzyny; Hydroksyzyny [Polish]; Hydroxine; Hydroxizine; Hydroxizinum; Hydroxycine; Hydroxyzin; Hydroxyzine; Hydroxyzine Base; Hydroxyzine Hcl; Hydroxyzine Pamoate; Hydroxyzinum [Inn-Latin]; Hydroxyzyne; Idrossizina; Idrossizina [Dcit]; Masmoran; NP 212; Neo-Calma; Neurozina; Nevrolaks; Orgatrax; Pamazone; Parenteral; Paxistil; Placidol; Plaxidol; Quiess; Tran-Q; Tranquizine; Traquizine; U.C.B 4492; U.CB 4492; UCB 4492; UCB 492; UCB-4492; Vesparaz-Wirkstoff; Vistaril; Vistaril Pamoate; Vistazine

Drug Category:
Atarax is categorized under the following by the FDA: Antipruritics; Histamine H1 Antagonists; Anxiolytics sedatives and hypnotics; ATC:N05BB01

Dosage Forms:
CAPSULE; LIQUID; SOLUTION; SYRUP

Absorption:
Rapidly absorbed from the gastrointestinal tract

Interactions:
[an error occurred while processing this directive]



Chemical IUPAC Name:
2-[2-[4-[(4-chlorophenyl)-phenyl-methyl]piperazin-1-yl]ethoxy]ethanol





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy